Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients

Table 3

Comparison between the mean level of inflammatory markers and methylation status of the promoter of HeyL gene in COVID-19 patients.

	COVID-19 patients			Control subjects
Proinflammatory markers	Partial-methylated	Unmethylated	1 value	Partial-methylated	Unmethylated	P2 value
PLR			0.021			0.76
CRP (mg/L)			0.044			0.133
Ferritin (ng/ml)			0.048			0.077
D-dimer (μg/ml)			0.026			0.21

1: significant value for comparing between the mean levels of inflammatory markers in COVID-19 patients according to methylation status of HeyL promoter. 2: significant value for comparing between the mean levels of inflammatory markers in control subjects according to methylation status of HeyL promoter. Statistically significant at .